Rebalancing Effector and Regulatory T cell Functions by Tumor Treating Fields (TTF) Therapeutic Potential of Targeting Immune Checkpoints for Cancer Treatment

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/232/28/25

Funding

  • Novocure GmbH: $89,659.00